Luckson Previl
Optometrist · Chattanooga, TNNPI 1780017483
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Alcon at 30.3% of the total. Among optometrist clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $49.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Bausch & Lomb Americas Inc.$856
- AbbVie$431
- Bausch & Lomb, A Division Of Bausch Health US, LLC$396
- Johnson & Johnson Surgical Vision, Inc.$361
- Coopervision Inc.$340
- plus $2K from 20 others
What the payments were for
- Grants$200%
- Food & beverage$6,875100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 42 | $2,093 |
| Bausch & Lomb Americas Inc. | 8 | $856 |
| AbbVie(2 entities) | 16 | $431 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $396 |
| Johnson & Johnson Surgical Vision, Inc. | 7 | $361 |
| Coopervision Inc. | 4 | $340 |
| Johnson & Johnson Vision Care, Inc. | 3 | $332 |
| Aerie Pharmaceuticals, Inc. | 4 | $252 |
| Sun Pharmaceutical Industries Inc. | 4 | $252 |
| Dompe US, Inc. | 6 | $223 |
| Glaukos Corporation | 2 | $220 |
| Amgen | 7 | $196 |
| Mallinckrodt Hospital Products Inc. | 8 | $159 |
| Carl Zeiss Meditec USA, Inc. | 1 | $130 |
| Biotissue Holdings Inc. | 5 | $110 |
| Rxsight Inc | 2 | $102 |
| Integra Lifesciences Corporation | 1 | $97 |
| Novartis | 4 | $64 |
| Optos, Inc. | 1 | $56 |
| Mallinckrodt Enterprises LLC | 2 | $54 |
| Tarsus Pharmaceuticals, Inc. | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| Oyster Point Pharma, Inc. | 1 | $24 |
| Alimera Sciences, Inc. | 1 | $22 |
| Eyevance Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis IOL$435
- INFUSE$360
- Clareon$264
- TOTAL30$229
- AcrySof IQ PanOptix$228
- Acuvue$218
- Clareon PanOptix Pro$155
- ARGOS$145
- QUATERA 700$130
- CEQUA$126
- ORA$126
- MIEBO$125
- XIIDRA$125
- LUMIGAN$125
- DURYSTA$125
- XEN GLAUCOMA TREATMENT SYSTEM$125
- Rhopressa$124
- Rocklatan$124
- VYZULTA$119
- ULTRA MULTIFOCAL TORIC$117
How this compares
$6,895 in reported general payments places this provider in the 95th percentile of 1,122 optometrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxervateCenegermin-Bkbj | 33 | $1,119,335 |
| RestasisCyclosporine | 69 | $62,741 |
| LumiganBimatoprost | 137 | $52,798 |
| XiidraLifitegrast | 34 | $47,500 |
| RocklatanNetarsudil Mesylat/Latanoprost | 83 | $35,208 |
| XdemvyLotilaner | 15 | $28,091 |
| ProlensaBromfenac Sodium | 62 | $21,775 |
| CombiganBrimonidine Tartrate/Timolol | 52 | $18,907 |
| RhopressaNetarsudil Mesylate | 19 | $12,414 |
| IlevroNepafenac | 31 | $11,259 |
| Cyclosporine | 13 | $8,688 |
| Latanoprost | 564 | $6,803 |
| Prednisolone Acetate | 215 | $6,662 |
| BesivanceBesifloxacin Hcl | 27 | $5,758 |
| Bromfenac Sodium | 29 | $5,165 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Dompe US, Inc.Oxervate | $223 | $1,119,33533 claims |
| AbbVieRestasis, Lumigan, Combigan | $431 | $134,446258 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $252 | $47,622102 claims |
| Bausch & Lomb Americas Inc.Xiidra | $856 | $47,50034 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa, Besivance, Loteprednol Etabonate | $396 | $28,740100 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $54 | $28,09115 claims |
| NovartisIlevro | $64 | $11,25931 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,122 optometrist providers in Tennessee.
Other optometrist in Chattanooga
- Mark KappermanChattanooga$27K
- Troy WhiteChattanooga$8K
- Christopher LievensMemphis$566K
- Whitney HauserMemphis$330K
- Torrey CarlsonKingsport$192K
- Frances BynumMartin$162K
- Melvin FriedmanMemphis$108K
- Kurt SteeleNewport$90K
- Jennifer DrakeColumbia$84K
- Travis JohnsonMurfreesboro$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.